Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Operating Expenses | 2,336 | 2,221 | 2,517 | 2,589 | 2,976 |
| Operating Income | -2,336 | -2,221 | -2,517 | -2,589 | -2,976 |
| Interest Expense | 144 | 137 | 101 | 0 | 0 |
| Other Income | 127 | -543 | 142 | -8 | -44 |
| Pre-tax Income | -2,354 | -2,901 | -2,476 | -2,596 | -3,020 |
| Net Income Continuous | -2,354 | -2,901 | -2,476 | -2,596 | -3,020 |
| Net Income | $-2,354 | $-2,901 | $-2,476 | $-2,596 | $-3,020 |
| EPS Basic Total Ops | -2,500.00 | -3,200.00 | -2,750.00 | -3,000.00 | -3,500.00 |
| EPS Basic Continuous Ops | -2,390.70 | -3,214.20 | -2,767.38 | -2,900.95 | -3,572.87 |
| EPS Diluted Total Ops | -2,500.00 | -3,200.00 | -2,750.00 | -3,000.00 | -3,500.00 |
| EPS Diluted Continuous Ops | -2,390.70 | -3,214.20 | -2,767.38 | -2,900.95 | -3,572.87 |
| EBITDA(a) | $-2,282 | $-2,174 | $-2,464 | $-2,551 | $-2,941 |